LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, May 02, 2024 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization...
Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, has promoted Patrick Cushing, Ph.D., to Vice President, Operations of Rentschler Biopharma, Inc., the company’s U.S. subsidiary.
Rentschler Takes Home the Gold in 20th Annual Team Economic Impact Awards
Rentschler contributes to nearly 25% of biopharmaceuticals in 2023
Senta Brandt promoted to global position of Head of TransformationGerrick Rodrigues promoted to Global Head of IT LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, Feb. 06, 2024 ...
Welcome to Endpoints News’ manufacturing news briefs, where we bring you essential updates on new builds, collaborations, recalls and more.
State-of-the-art Rentschler Biopharma Manufacturing Center (RBMC) facility slated to open for business next year LAUPHEIM, Germany and MILFORD, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Rentschler...
LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO)...
Rentschler Biopharma SE, a global CDMO for biopharmaceuticals, appointed Benedikt von Braunmuehl Chief Executive Officer. Von Braunmuehl brings 30 years of experience in the global healthcare industry and has a track record of successfully implementing effective business strategies to achieve corporate growth goals.
Benedikt von Braunmuehl, a transformational leader with a 30-year track record in the global healthcare industry, is named CEO Rentschler Biopharma SECompany also announces appointment of Tom Roberts,...